InMed completes private placement

On Jan. 18, cannabinoid-based therapeutics developer InMed Pharmaceuticals Inc. (CNSX:IN; OTCQB:IMLFF) raised C$1.5 million ($1.1 million) through the sale of 8.3 million shares at C$0.18 in a privat...